Redcare Pharmacy valuation
€63.40Change from previous close: −1.93%Absolute change: −€1.25
Valuation
The average price target of 10 analysts is €91.60.
Data as of November 21, 2026
Redcare Pharmacy compared with similar companies
Redcare Pharmacy's Forward P/E: 49.4, +208% against the median of a group of 9 similar companies (16.0).
| Metric | Redcare Pharmacy | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Forward P/E | 49.4 | 16.0 | 12.5 – 19.5 | High |
| EV/EBITDA | 52.8 | 11.1 | 10.1 – 18.5 | High |
| Price/book | 2.91 | 3.10 | 2.46 – 7.19 | Middle |
| Price/sales | 0.40 | 0.66 | 0.48 – 1.28 | Low |
| Gross margin | 21.5% | 25.4% | 24.3% – 40.4% | Low |
| Operating margin | 0.3% | 6.1% | 4.3% – 6.5% | Low |
| Net margin | -1.0% | 3.1% | 2.1% – 6.8% | Low |
| ROE | -7.1% | 19.2% | 10.9% – 34.5% | Low |
| Debt/equity | 0.74 | 1.15 | 0.64 – 2.44 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same and related industries, similar size
Other metrics
Valuation multiples
- Market cap
- €1.34B
- Enterprise value
- €1.61B
- P/E (trailing 12 months)
- -34.7
- EV/revenue
- 0.48
Profitability and growth
- ROA
- 0.5%
- ROIC
- 0.7%
- Revenue growth (year over year)
- 17.7%
- Earnings growth (year over year)
- -50.4%
Financial health
- Total cash
- €132.4M
- Total debt
- €354.5M
- Current ratio
- 1.62
- Quick ratio
- 0.81
- Piotroski F-Score
- 3.00
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- €91.60
- Median price target
- €90.50
- High price target
- €125.00
- Low price target
- €72.00
- Analysts with a price target
- 10
- Consensus
- Buy
- Forward EPS
- €1.35
- EPS estimate, current year
- -€0.31
Shares and trading
- Beta
- 1.45
- Average volume
- 84.09K
- Shares outstanding
- 20.11M
- Float
- 19.2M
- Institutional ownership
- 36.2%
- Insider ownership
- 18.7%
